Ouster, Inc. has announced a significant transaction involving the sale of common stock by one of its directors, Susan Heystee. On November 10, 2026, Heystee sold 7,551 shares, valued at approximately $282,731. This transaction may indicate shifts in ownership dynamics and could impact investor perceptions of the company.
Background
Ouster, Inc. operates in the General Industrial Machinery & Equipment sector, specifically under the SIC code 3569. The company is listed on the Nasdaq under the ticker symbol OUST. Recent filings include a Form 10-Q and an 8-K, which provide insights into the company’s performance and strategic direction.
What the Filing Says
The SEC filing, identified by accession number 0001950047-26-010912, details the sale of shares by Heystee, who is a director at Ouster. The filing states, "The approximate sale date was 11/10/2026," confirming the timing of the transaction.
Impact
This sale may affect various stakeholders, including shareholders and potential investors, as it reflects the actions of a company insider. The transaction could influence market perceptions of Ouster's stability and growth potential within the competitive landscape of the General Industrial Machinery & Equipment sector.
What's Next
The filing does not say what happens next.
Details of Share Acquisition
In addition to the sale of shares, the SEC filing provides information about the shares that Susan Heystee acquired prior to the sale. Heystee received a total of 6,661 shares through restricted stock transactions on various dates: 1,712 shares on July 7, 2025, 1,010 shares on October 6, 2025, 3,390 shares on June 17, 2026, 660 shares on July 6, 2026, and 779 shares on October 5, 2026. These acquisitions reflect her ongoing involvement and investment in Ouster, Inc.
Current Outstanding Shares
The filing also notes that there are currently 72,997,169 shares of common stock outstanding for Ouster, Inc. This figure is crucial for understanding the scale of the transaction in relation to the company's overall equity structure.
Brokerage Information
The transaction was facilitated by Morgan Stanley Smith Barney LLC Executive Financial Services, indicating a reputable brokerage firm was involved in the sale process. This could lend additional credibility to the transaction from an investor's perspective.
Conclusion
The filing does not provide insights into the reasons behind Heystee's decision to sell her shares or any future plans she may have regarding her stake in Ouster, Inc.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










